201 related articles for article (PubMed ID: 17002217)
1. Recent advances in positive allosteric modulators of the AMPA receptor.
Morrow JA; Maclean JK; Jamieson C
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
[TBL] [Abstract][Full Text] [Related]
2. AMPA receptor modulators as cognitive enhancers.
Lynch G
Curr Opin Pharmacol; 2004 Feb; 4(1):4-11. PubMed ID: 15018832
[TBL] [Abstract][Full Text] [Related]
3. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
Yamada KA
Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor potentiators as cognitive enhancers.
O'Neill MJ; Dix S
IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms of AMPA receptors in synaptic plasticity.
Derkach VA; Oh MC; Guire ES; Soderling TR
Nat Rev Neurosci; 2007 Feb; 8(2):101-13. PubMed ID: 17237803
[TBL] [Abstract][Full Text] [Related]
6. The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.
Mellor IR
Future Med Chem; 2010 May; 2(5):877-91. PubMed ID: 21426207
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
Lees GJ
Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
[TBL] [Abstract][Full Text] [Related]
8. AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins.
Strømgaard K; Mellor I
Med Res Rev; 2004 Sep; 24(5):589-620. PubMed ID: 15224382
[TBL] [Abstract][Full Text] [Related]
9. Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
Grove SJ; Jamieson C; Maclean JK; Morrow JA; Rankovic Z
J Med Chem; 2010 Oct; 53(20):7271-9. PubMed ID: 20839777
[No Abstract] [Full Text] [Related]
10. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
Raevskiĭ KS; Eremin KO
Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
[TBL] [Abstract][Full Text] [Related]
11. A role for AMPA receptors in mood disorders.
Alt A; Nisenbaum ES; Bleakman D; Witkin JM
Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
[TBL] [Abstract][Full Text] [Related]
12. Competitive AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F
Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
[TBL] [Abstract][Full Text] [Related]
13. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.
Siuda ER; Quirk JC; Nisenbaum ES
Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986
[TBL] [Abstract][Full Text] [Related]
14. AMPA receptor potentiators for the treatment of CNS disorders.
O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
[TBL] [Abstract][Full Text] [Related]
15. Structural aspects of AMPA receptor activation, desensitization and deactivation.
Hansen KB; Yuan H; Traynelis SF
Curr Opin Neurobiol; 2007 Jun; 17(3):281-8. PubMed ID: 17419047
[TBL] [Abstract][Full Text] [Related]
16. Structure and different conformational states of native AMPA receptor complexes.
Nakagawa T; Cheng Y; Ramm E; Sheng M; Walz T
Nature; 2005 Feb; 433(7025):545-9. PubMed ID: 15690046
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional structure of an AMPA receptor without associated stargazin/TARP proteins.
Nakagawa T; Cheng Y; Sheng M; Walz T
Biol Chem; 2006 Feb; 387(2):179-87. PubMed ID: 16497150
[TBL] [Abstract][Full Text] [Related]
18. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.
Chang PK; Verbich D; McKinney RA
Eur J Neurosci; 2012 Jun; 35(12):1908-16. PubMed ID: 22708602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
